Información del producto
Quinaprilat hydrate is a prodrug of quinapril that inhibits the activity of angiotensin-converting enzyme (ACE). Quinaprilat hydrate has been shown to be effective in reducing blood pressure and improving symptoms of congestive heart failure. The oral prodrug is converted to the active form, quinapril, by esterases in the bowel. This process can be inhibited by drugs such as cimetidine, which blocks the activity of esterases. Quinaprilat hydrate has been found to have antioxidative properties, which may reduce myocardial infarct size and improve cardiac function in vitro. The drug also reduces levels of a protein called PSCK9 that can lead to high cholesterol and heart disease.
Propiedades químicas
Consulta técnica sobre: 3D-KHC78609 Quinaprilat hydrate
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
